Early research (Phase 1)Study completedNCT01704872What this trial is testingCh14.18/CHO Bridging StudyWho this might be right forNeuroblastoma St. Anna Kinderkrebsforschung 16
Testing effectiveness (Phase 2)Study completedNCT03213665What this trial is testingTazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Hodgkin LymphomaAnn Arbor Stage III Non-Hodgkin Lymphoma+38 more National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00077454What this trial is testingErlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid TumorsWho this might be right forPreviously Treated Childhood RhabdomyosarcomaRecurrent Childhood Brain TumorRecurrent Childhood Cerebellar Astrocytoma+9 more National Cancer Institute (NCI) 95
Early research (Phase 1)Study completedNCT03966651What this trial is testingA Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.Who this might be right forNeuroblastoma Institut Claudius Regaud 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT05726864What this trial is testingELI-002 7P in Subjects With KRAS/NRAS Mutated Solid TumorsWho this might be right forPancreatic Ductal AdenocarcinomaColorectal CancerKRAS G12D+11 more Elicio Therapeutics 158
Early research (Phase 1)Study completedNCT00060372What this trial is testingIpilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)Study completedNCT00045292What this trial is testingValacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center
Not applicableAvailableNCT03015844What this trial is testingA Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic PheochromocytomaWho this might be right forNeuroblastomaPheochromocytoma Northwell Health
Testing effectiveness (Phase 2)Study completedNCT00109993What this trial is testingCampath-1H + FK506 and Methylprednisolone for GVHDWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Case Comprehensive Cancer Center 34
Early research (Phase 1)Study completedNCT00638898What this trial is testingBusulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid TumorWho this might be right forSolid TumorAdult Central Nervous System Germ Cell TumorAdult Rhabdomyosarcoma+27 more City of Hope Medical Center 25
Not applicableEnded earlyNCT00957736What this trial is testingChronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forCancer Vanderbilt-Ingram Cancer Center 252
Not applicableStudy completedNCT01510600What this trial is testingStudying Biomarkers in Samples From Patients With High-Risk NeuroblastomaWho this might be right forNeuroblastoma Children's Oncology Group 99
Testing effectiveness (Phase 2)Study completedNCT00003565What this trial is testingDocetaxel in Treating Patients With Solid TumorsWho this might be right forBladder CancerBreast CancerHead and Neck Cancer+2 more Alliance for Clinical Trials in Oncology 109
Early research (Phase 1)Study completedNCT01331135What this trial is testingAflac ST0901 CHOANOME - Sirolimus in Solid TumorsWho this might be right forEwing's SarcomaOsteosarcomaAstrocytoma+13 more Emory University 18
Early research (Phase 1)Looking for participantsNCT06674265What this trial is testingSafety and Efficacy of Systemic Allogenic NK Cells in R/R NeuroblastomaWho this might be right forNeuroblastoma, Recurrent, RefractoryNeuroblastoma (NB)Neuroblastoma in Children Marzieh Ebrahimi 10
Large-scale testing (Phase 3)UnknownNCT00030719What this trial is testingCombination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With NeuroblastomaWho this might be right forNeuroblastoma University of Leicester 175
Testing effectiveness (Phase 2)Looking for participantsNCT06814496What this trial is testingRadiation Combined With BIspecific T-Cell Engager in DLL3 Expressing TumorsWho this might be right forMelanomaMedullary Thyroid CancerSinonasal Undifferentiated Carcinoma+8 more University of Arizona 30
Testing effectiveness (Phase 2)Study completedNCT03233204What this trial is testingOlaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+33 more National Cancer Institute (NCI) 6
Not applicableNo Longer AvailableNCT02431715What this trial is testing18F-FDOPA PET in Neuroendocrine TumoursWho this might be right forThyroid Cancer, MedullaryCarcinoid TumorPheochromocytoma+3 more British Columbia Cancer Agency
Not applicableLooking for participantsNCT04253015What this trial is testingA Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab BetaWho this might be right forNeuroblastoma RECORDATI GROUP 125